Cargando…
Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease β-amyloid production
Glycogen synthase kinase 3 (GSK-3) dysregulation is implicated in the two Alzheimer's disease (AD) pathological hallmarks: β-amyloid plaques and neurofibrillary tangles. GSK-3 inhibitors may abrogate AD pathology by inhibiting amyloidogenic γ-secretase cleavage of amyloid precursor protein (APP...
Autores principales: | Rezai-Zadeh, Kavon, Douglas Shytle, R, Bai, Yun, Tian, Jun, Hou, Huayan, Mori, Takashi, Zeng, Jin, Obregon, Demian, Town, Terrence, Tan, Jun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671567/ https://www.ncbi.nlm.nih.gov/pubmed/18410522 http://dx.doi.org/10.1111/j.1582-4934.2008.00344.x |
Ejemplares similares
-
Mutant presenilin-1 deregulated peripheral immunity exacerbates Alzheimer-like pathology
por: Zhu, Yuyan, et al.
Publicado: (2011) -
Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer’s Transgenic Mice
por: Douglas Shytle, R, et al.
Publicado: (2012) -
Macrophages in Alzheimer’s disease: the blood-borne identity
por: Gate, David, et al.
Publicado: (2010) -
Octyl Gallate Markedly Promotes Anti-Amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation
por: Zhang, She-Qing, et al.
Publicado: (2013) -
CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
por: Rezai-Zadeh, Kavon, et al.
Publicado: (2009)